EcoDrugPlus

Adenosine A2b Receptor

Ensembl ID : ENSOMYG00000024093
Gene Symbol: ADORA2B
1 Cross references
192 Possible Orthologues:

Adenosine Deaminase

Ensembl ID : ENSOMYG00000020364
Gene Symbol: ADA
1 Cross references
210 Possible Orthologues:

Adenosine Deaminase

Ensembl ID : ENSOMYG00000029961
Gene Symbol: ADA
1 Cross references
210 Possible Orthologues:

Adhesion Regulating Molecule 1

Ensembl ID : ENSOMYG00000033827
Gene Symbol: ADRM1
1 Cross references
194 Possible Orthologues:

Adrenergic, Alpha-1a-, Receptor

Ensembl ID : ENSOMYG00000019142
Gene Symbol: ADRA1A
2 Cross references
196 Possible Orthologues:

Adrenoceptor Alpha 1aa

Ensembl ID : ENSOMYG00000036375
Gene Symbol: ADRA1AA
1 Cross references
196 Possible Orthologues:

Adrenoceptor Alpha 1b

Ensembl ID : ENSOMYG00000047535
Gene Symbol: ADRA1B
1 Cross references
190 Possible Orthologues:

Adrenoceptor Alpha 1b

Ensembl ID : ENSOMYG00000017725
Gene Symbol: ADRA1B
2 Cross references
190 Possible Orthologues:

Adrenoceptor Alpha 2a

Ensembl ID : ENSOMYG00000009116
Gene Symbol: ADRA2A
1 Cross references
170 Possible Orthologues:

Adrenoceptor Alpha 2a

Ensembl ID : ENSOMYG00000077571
Gene Symbol: ADRA2A
1 Cross references
171 Possible Orthologues:

Adrenoceptor Alpha 2b

Ensembl ID : ENSOMYG00000047243
Gene Symbol: ADRA2B
1 Cross references
168 Possible Orthologues:

Adrenoceptor Alpha 2c

Ensembl ID : ENSOMYG00000072596
Gene Symbol: ADRA2C
1 Cross references
159 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).